FdaApplication
ANDA 206421
Identifiers
- fda_app_no: ANDA206421
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2018-12-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXEMESTANE | EXEMESTANE | 25MG | TABLET;ORAL |
1 product